Oci Nv

OCI NV's capital structure is characterized by a low debt-to-equity ratio of 0.14, indicating a conservative leverage position relative to its equity base. However, the company's liquidity position is rated as medium, with negative net cash after subtracting total debt. The current ratio of 1.34 suggests the company has sufficient current assets to cover its short-term liabilities, but the negative operating cash flow of -82.2 million USD and free cash flow of -2.03 billion USD indicate significant cash outflows.

Profitability metrics show mixed results. The company's return on equity (ROE) of 17.1% is strong, but its return on assets (ROA) of 9.99% is relatively modest. The operating income is negative at -185.2 million USD, which contrasts with a net income of 183.7 million USD, suggesting non-operating gains or other income sources are contributing to profitability. These figures are compared against industry benchmarks for Agricultural Chemicals, where ROE and ROA are typically influenced by commodity price volatility and production efficiency.

OCI NV's geographic and segment exposure is not explicitly detailed in the available data, but the company's primary business is in the production and distribution of agricultural chemicals. Revenue concentration is not specified, but the company's operations are likely influenced by global agricultural demand and regional regulatory environments.

The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. Historical revenue data shows a total of 1.086 billion USD in the most recent period, but the operating income is negative, indicating potential challenges in maintaining or growing revenue. The company's capital expenditure of -120.2 million USD suggests ongoing investment in infrastructure or production capacity, which could support future growth.

Risk factors include a medium liquidity risk due to negative net cash and a low dilution risk. The company's risk assessment highlights the importance of monitoring its cash flow and debt management strategies. No significant dilution sources are identified, and the dilution potential is rated as low. The company's financial health is also influenced by its ability to manage operating losses and maintain positive cash flows.

Recent events and filings do not provide specific details on new projects or strategic initiatives. The company's financial performance and risk profile are primarily derived from its latest financial statements and analyst estimates. The mean price target of 3.85 USD and median price target of 3.75 USD suggest a cautious outlook from analysts, with a mean recommendation of 2.86, indicating a "hold" rating.